Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-02-16 | Dr. James Mathew RouthCEO & Executive Director | 18,70k | 0,00 | Derivative Exercise and Retained Stock | - | 36,26k | 106,52% |
| 2026-02-16 | Dr. James Mathew RouthCEO & Executive Director | -28,33k | 271,49k | Derivative Exercise and Sale | 9,58 | 36,26k | - |
| 2026-02-12 | Dr. James Mathew RouthCEO & Executive Director | 172,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-02-12 | Dr. James Mathew RouthCEO & Executive Director | 146,45k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-02-12 | Dr. James Mathew RouthCEO & Executive Director | 13,04k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-02-10 | Mr. Ian Clifford MellingCFO & Executive Director | 3,31k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-17 | Mr. Ian Clifford MellingCFO & Executive Director | 3,50k | 30,14k | Achat | 8,61 | 13,35k | 35,53% |
| 2025-12-17 | Mr. Ian Clifford MellingCFO & Executive Director | 2,85k | 0,00 | Derivative Exercise and Retained Stock | - | 9,85k | 40,71% |
| 2025-12-17 | Mr. Ian Clifford MellingCFO & Executive Director | -2,55k | 22,02k | Derivative Exercise and Sale | 8,65 | 9,85k | - |
| 2025-12-12 | Mr. Jakob Oskar SigurdssonInitié | 15,48k | 134,00k | Derivative Exercise and Retained Stock | 8,66 | 94,21k | 19,66% |
| 2025-12-12 | Mr. Jakob Oskar SigurdssonInitié | -13,82k | 0,00 | Derivative Exercise and Sale | 8,66 | 94,21k | - |
| 2025-12-10 | Mr. Jakob Oskar SigurdssonInitié | 16,19k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-10 | Mr. Ian Clifford MellingCFO & Executive Director | 104,40k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-12-05 | Dr. James Mathew RouthCEO & Executive Director | 4,52k | 40,01k | Achat | 8,84 - 8,87 | 4,52k | - |
| 2025-07-08 | Dr. Dame Vivienne CoxIndependent Non-Executive Chair | 2,75k | 26,86k | Achat | 9,78 | 6,95k | 65,30% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
